nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.0375	0.15	CbGeAlD
Eletriptan—HTR1F—nervous system—Gilles de la Tourette syndrome	0.015	0.0601	CbGeAlD
Eletriptan—HTR1F—central nervous system—Gilles de la Tourette syndrome	0.0145	0.0579	CbGeAlD
Eletriptan—HTR1E—nervous system—Gilles de la Tourette syndrome	0.013	0.0521	CbGeAlD
Eletriptan—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.0125	0.0501	CbGeAlD
Eletriptan—HTR1F—brain—Gilles de la Tourette syndrome	0.0115	0.0459	CbGeAlD
Eletriptan—HTR1E—brain—Gilles de la Tourette syndrome	0.00994	0.0398	CbGeAlD
Eletriptan—Sumatriptan—DRD2—Gilles de la Tourette syndrome	0.00888	0.29	CrCbGaD
Eletriptan—HTR7—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00751	0.0104	CbGpPWpGaD
Eletriptan—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00748	0.03	CbGeAlD
Eletriptan—HTR1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00746	0.0104	CbGpPWpGaD
Eletriptan—HTR1F—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00739	0.0103	CbGpPWpGaD
Eletriptan—HTR1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00731	0.0102	CbGpPWpGaD
Eletriptan—HTR7—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00729	0.0101	CbGpPWpGaD
Eletriptan—HTR1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00725	0.0101	CbGpPWpGaD
Eletriptan—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00724	0.029	CbGeAlD
Eletriptan—HTR1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00709	0.00986	CbGpPWpGaD
Eletriptan—HTR1E—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00697	0.00969	CbGpPWpGaD
Eletriptan—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.00691	0.225	CrCbGaD
Eletriptan—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00686	0.00954	CbGpPWpGaD
Eletriptan—HTR7—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00679	0.00944	CbGpPWpGaD
Eletriptan—HTR1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00675	0.00938	CbGpPWpGaD
Eletriptan—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00666	0.00926	CbGpPWpGaD
Eletriptan—HTR1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00661	0.00919	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00653	0.00907	CbGpPWpGaD
Eletriptan—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00649	0.00902	CbGpPWpGaD
Eletriptan—HTR7—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00631	0.00878	CbGpPWpGaD
Eletriptan—HTR1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00627	0.00872	CbGpPWpGaD
Eletriptan—HTR1F—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00621	0.00864	CbGpPWpGaD
Eletriptan—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00621	0.00863	CbGpPWpGaD
Eletriptan—HTR1B—nervous system—Gilles de la Tourette syndrome	0.00615	0.0246	CbGeAlD
Eletriptan—HTR1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00614	0.00854	CbGpPWpGaD
Eletriptan—HTR7—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00613	0.00852	CbGpPWpGaD
Eletriptan—HTR1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00609	0.00846	CbGpPWpGaD
Eletriptan—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00604	0.0242	CbGeAlD
Eletriptan—HTR1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00596	0.00829	CbGpPWpGaD
Eletriptan—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00596	0.0238	CbGeAlD
Eletriptan—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00592	0.0237	CbGeAlD
Eletriptan—HTR1E—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00586	0.00815	CbGpPWpGaD
Eletriptan—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00577	0.00802	CbGpPWpGaD
Eletriptan—HTR7—midbrain—Gilles de la Tourette syndrome	0.00577	0.0231	CbGeAlD
Eletriptan—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00573	0.023	CbGeAlD
Eletriptan—HTR7—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00571	0.00794	CbGpPWpGaD
Eletriptan—HTR1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00567	0.00789	CbGpPWpGaD
Eletriptan—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0056	0.00779	CbGpPWpGaD
Eletriptan—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00557	0.00774	CbGpPWpGaD
Eletriptan—HTR1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00556	0.00772	CbGpPWpGaD
Eletriptan—HTR2B—nervous system—Gilles de la Tourette syndrome	0.00554	0.0222	CbGeAlD
Eletriptan—CYP2A6—brain—Gilles de la Tourette syndrome	0.00551	0.022	CbGeAlD
Eletriptan—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0054	0.00751	CbGpPWpGaD
Eletriptan—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.00533	0.0213	CbGeAlD
Eletriptan—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00522	0.00725	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00518	0.00721	CbGpPWpGaD
Eletriptan—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00503	0.007	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00503	0.00699	CbGpPWpGaD
Eletriptan—HTR1A—nervous system—Gilles de la Tourette syndrome	0.00496	0.0199	CbGeAlD
Eletriptan—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.00478	0.156	CrCbGaD
Eletriptan—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.00478	0.0191	CbGeAlD
Eletriptan—HTR7—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00476	0.00661	CbGpPWpGaD
Eletriptan—HTR7—nervous system—Gilles de la Tourette syndrome	0.00474	0.019	CbGeAlD
Eletriptan—HTR1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00473	0.00657	CbGpPWpGaD
Eletriptan—HTR1B—brain—Gilles de la Tourette syndrome	0.0047	0.0188	CbGeAlD
Eletriptan—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00468	0.0065	CbGpPWpGaD
Eletriptan—HTR1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00463	0.00643	CbGpPWpGaD
Eletriptan—HTR7—central nervous system—Gilles de la Tourette syndrome	0.00457	0.0183	CbGeAlD
Eletriptan—HTR1D—brain—Gilles de la Tourette syndrome	0.00455	0.0182	CbGeAlD
Eletriptan—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00454	0.00631	CbGpPWpGaD
Eletriptan—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00435	0.00604	CbGpPWpGaD
Eletriptan—HTR2B—brain—Gilles de la Tourette syndrome	0.00423	0.0169	CbGeAlD
Eletriptan—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00423	0.00588	CbGpPWpGaD
Eletriptan—HTR7—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.004	0.00556	CbGpPWpGaD
Eletriptan—HTR1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00397	0.00552	CbGpPWpGaD
Eletriptan—HTR1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00389	0.00541	CbGpPWpGaD
Eletriptan—HTR1A—brain—Gilles de la Tourette syndrome	0.00379	0.0152	CbGeAlD
Eletriptan—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.0037	0.121	CrCbGaD
Eletriptan—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00366	0.00508	CbGpPWpGaD
Eletriptan—HTR7—brain—Gilles de la Tourette syndrome	0.00363	0.0145	CbGeAlD
Eletriptan—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.00361	0.118	CrCbGaD
Eletriptan—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00353	0.0049	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00334	0.00464	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00328	0.00456	CbGpPWpGaD
Eletriptan—PTGS1—nervous system—Gilles de la Tourette syndrome	0.00328	0.0131	CbGeAlD
Eletriptan—HTR7—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00324	0.0045	CbGpPWpGaD
Eletriptan—PTGS1—central nervous system—Gilles de la Tourette syndrome	0.00316	0.0126	CbGeAlD
Eletriptan—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00296	0.00412	CbGpPWpGaD
Eletriptan—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.00279	0.0909	CrCbGaD
Eletriptan—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00274	0.011	CbGeAlD
Eletriptan—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00269	0.0108	CbGeAlD
Eletriptan—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00264	0.0106	CbGeAlD
Eletriptan—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00259	0.0104	CbGeAlD
Eletriptan—PTGS1—brain—Gilles de la Tourette syndrome	0.00251	0.01	CbGeAlD
Eletriptan—HTR1F—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00243	0.00337	CbGpPWpGaD
Eletriptan—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00236	0.00944	CbGeAlD
Eletriptan—HTR1F—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00236	0.00327	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00229	0.00318	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00225	0.00313	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00222	0.00309	CbGpPWpGaD
Eletriptan—HTR1F—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00219	0.00305	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00219	0.00304	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00212	0.00295	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00294	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00207	0.00288	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00206	0.00287	CbGpPWpGaD
Eletriptan—CYP2D6—brain—Gilles de la Tourette syndrome	0.00206	0.00825	CbGeAlD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00204	0.00283	CbGpPWpGaD
Eletriptan—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00194	0.00776	CbGeAlD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00193	0.00268	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00192	0.00267	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00187	0.0026	CbGpPWpGaD
Eletriptan—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00187	0.00747	CbGeAlD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00182	0.00253	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00177	0.00246	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00177	0.00246	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00175	0.00243	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00172	0.00239	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00165	0.00229	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0016	0.00223	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00155	0.00216	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00152	0.00211	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00151	0.00209	CbGpPWpGaD
Eletriptan—ABCB1—brain—Gilles de la Tourette syndrome	0.00148	0.00593	CbGeAlD
Eletriptan—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00148	0.00205	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00147	0.00204	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00145	0.00201	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00144	0.002	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00198	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00143	0.00198	CbGpPWpGaD
Eletriptan—CYP2A6—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00142	0.00198	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00141	0.00196	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00141	0.00196	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0014	0.00195	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0014	0.00194	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00139	0.00193	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00137	0.00191	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00137	0.0019	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00135	0.00187	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00135	0.00187	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00133	0.00185	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00132	0.00184	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00131	0.00182	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0013	0.00181	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00129	0.00179	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00128	0.00177	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00125	0.00174	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00124	0.00173	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00123	0.00172	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00122	0.0017	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00121	0.00168	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00121	0.00168	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0012	0.00167	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0012	0.00166	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00117	0.00163	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00116	0.00161	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00115	0.0016	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00114	0.00158	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00112	0.00156	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00112	0.00156	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00112	0.00155	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0011	0.00153	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00109	0.00152	CbGpPWpGaD
Eletriptan—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00109	0.00151	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00107	0.00149	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00105	0.00146	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00104	0.00145	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00103	0.00143	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00141	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000972	0.00135	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000971	0.00135	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000946	0.00131	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00094	0.00131	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000931	0.00129	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00092	0.00128	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00092	0.00128	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000918	0.00128	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000918	0.00128	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000912	0.00127	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000912	0.00127	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000894	0.00124	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000893	0.00124	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000893	0.00124	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000878	0.00122	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000864	0.0012	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000855	0.00119	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00085	0.00118	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000839	0.00117	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000839	0.00117	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000832	0.00116	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000832	0.00116	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00083	0.00115	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000806	0.00112	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000787	0.00109	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000783	0.00109	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000782	0.00109	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000782	0.00109	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000765	0.00106	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00076	0.00106	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000754	0.00105	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000751	0.00104	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000732	0.00102	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000719	0.000999	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000711	0.000989	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000708	0.000985	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000701	0.000974	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000691	0.00096	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000682	0.000948	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00068	0.000946	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00068	0.000946	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000649	0.000902	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000643	0.000894	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000634	0.000881	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000614	0.000853	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000599	0.000833	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000595	0.000827	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000583	0.00081	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000583	0.00081	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000547	0.000761	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000535	0.000743	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000531	0.000738	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000526	0.000731	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00052	0.000723	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000519	0.000721	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000516	0.000717	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000505	0.000702	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000496	0.00069	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000488	0.000679	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000485	0.000675	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000483	0.000672	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000482	0.00067	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00048	0.000667	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000478	0.000664	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000474	0.000659	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000472	0.000656	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000471	0.000655	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00047	0.000654	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000468	0.000651	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000458	0.000637	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000451	0.000626	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000445	0.000619	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000444	0.000617	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000444	0.000616	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000442	0.000614	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000439	0.00061	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000436	0.000606	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000432	0.000601	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000431	0.000598	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000427	0.000594	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00042	0.000584	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000408	0.000567	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000403	0.00056	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000401	0.000558	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000396	0.000551	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000385	0.000534	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00038	0.000528	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.000374	0.00052	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000365	0.000508	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00036	0.0005	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000358	0.000498	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000349	0.000485	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000344	0.000478	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000341	0.000474	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000339	0.000471	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000336	0.000467	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000329	0.000458	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000325	0.000452	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000309	0.00043	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000307	0.000427	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000305	0.000425	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000299	0.000416	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000287	0.000399	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000285	0.000396	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000282	0.000392	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000281	0.00039	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000279	0.000388	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000278	0.000387	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000277	0.000384	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000271	0.000377	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000271	0.000376	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000266	0.00037	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000262	0.000364	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000259	0.00036	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000258	0.000358	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000254	0.000354	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000252	0.000351	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000251	0.000349	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000237	0.000329	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000228	0.000317	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000225	0.000313	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000212	0.000295	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000206	0.000287	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000192	0.000267	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000182	0.000252	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00018	0.000251	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000177	0.000246	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000166	0.000231	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000135	0.000187	CbGpPWpGaD
